Psychometric properties of the modified fatigue impact scale

International Journal of MS Care

Volumn 15, Issue 1, 2013, Pages 15-20

  Larson, Rebecca D ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880629572     PISSN: 15372073     EISSN: None     Source Type: Journal    
DOI: 10.7224/1537-2073.2012-019     Document Type: Article

References (19)

1. Romberg A, Virtanen A, Aunola S, Karppi SL, Karanko H, Ruutiainen J. Exercise capacity, disability and leisure physical activity of subjects with multiple sclerosis. Mult Scler. 2004;10:212-218.
2. Carroll CC, Gallagher PM, Seidle ME, Trappe SW. Skeletal muscle characteristics of people with multiple sclerosis. Arch Phys Med Rehabil. 2005;86:224-229.
3. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994;21:9-14.
4. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil. 1984;65:135-138.
5. Kos D, Nagels G, D'Hooghe MB, Duportail M, Kerckhofs E. A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurol. 2006;6:27.
6. Lapierre Y, Hum S. Treating fatigue. Int MS J. 2007;14:64-71.
7. Multiple Sclerosis Council. Fatigue and multiple sclerosis-clinical practice guideline. Paralyzed Veterans of America; 1998. http://www.kintera. org/AccountTempFiles/Account403152/ECSoft/MS-FatigueCPG. pdf 2003.
8. Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW, LaRocca NG. MSQLI: Multiple Sclerosis Quality of Life Inventory: A User's Manual. New York, NY: National Multiple Sclerosis Society; 1997.
9. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-1123.
10. Kos D, Kerckhofs E, Carrea I, Verza R, Ramos M, Jansa J. Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler. 2005;11:76-80.
11. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler. 2005;11:198-202.
12. Flachenecker P, Kumpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 2002;8:523-526.
13. Kos D, Kerckhofs E, Nagels G, et al. Assessing fatigue in multiple sclerosis: Dutch Modified Fatigue Impact Scale. Acta Neurol Belg. 2003;103:185-191.
14. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry. 2002;72:179-183.
15. Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology. 2005;64:1139-1143.
16. Greim B, Benecke R, Zettl UK. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS). J Neurol. 2007;254(suppl 2): II58-II64.
17. Kos D, Duportail M, D'hooghe M, Nagels G, Kerckhofs E. Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler. 2007;13:996-1003.
18. Mills RJ, Young CA, Pallant JF, Tennant A. Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2010;81:1049-1051.
19. Wright BD, Linacre JM. Observations are always ordinal; measurements, however, must be interval. Arch Phys Med Rehabil. 1989;70:857-860